oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Signopam

Reduced temazepam release may lead to insufficient patient exposure, lack of hypnotic and sedative efficacy, and risk of inappropriate treatment, including dose escalation and variability of effect. Potential effects: reduced treatment efficacy, need to change therapy.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Signopam
Risk Level
Medium
Manufacturer
Tarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
Batch Number
11122
Recall Date
06.10.2025
View official statement

Important Information

What You Should Know

Recommendations

Do not use the product from batch 11122; patients should check the batch number on the pack and return any packs from this batch to a pharmacy; in case of doubts or treatment problems, consult a docto...

Actions Taken

Withdrawal of batch 11122 of Signopam from the market throughout the country, prohibition of placing this batch on the market, and granting the decision immediate enforceability.

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: Reduced temazepam release may lead to insufficient patient exposure, lack of hypnotic and sedative efficacy, and risk of inappropriate treatment, including dose escalation and variability of effect. Potential effects: reduced treatment efficacy, need to change therapy.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.

Related

Other Recalled Products